Tuberculosis Testing

TB Risk Groups

Who is at risk for TB?

Tuberculosis (TB) can affect anyone, but certain groups are more vulnerable to TB than others. People who are frequently in contact with active TB cases in their home or workplace are more likely to be infected with TB. Those who are immunosuppressed or immunocompromised are more likely to progress from TB infection to active TB disease.  

What groups are at higher risk for tuberculosis infection?

Groups at higher risk for tuberculosis infection (TBI) and TB transmission include close contacts of active TB cases, people from areas with a high incidence of TB, children and residents or employees of congregate settings like long-term care and correctional facilities. Healthcare providers also require screening for TB to help prevent transmission to vulnerable patients and colleagues.

Who is at increased risk for developing active TB disease?

People more likely to progress from TB infection to active TB disease include those who were recently infected, people living with HIV, those receiving immunosuppressive therapy (such as TNF-a inhibitors) and children aged <5 years.

Adopt an accurate and convenient latent TB test
Get in touch with us to find out more about latent TB testing solutions.

What is a TB risk assessment?

A TB risk assessment helps to identify people at risk for tuberculosis who may require testing for TB infection or additional medical evaluation. Risk assessment is often part of a routine medical evaluation, especially for those entering a high-risk employment or living setting such as a healthcare facility, correctional facility, school or university. 

TB risk factors

Risk factors for tuberculosis acquisition or infection include certain medical conditions, country of birth, recent close contact with TB and recent travel history. Risk factors identified by the WHO and the US CDC include (1,2): 

  • Conditions such as HIV/AIDS, cancer or organ transplant
  • Dialysis or chronic kidney disease (CKD)
  • Immunosuppression, TNF inhibitors, corticosteroids
  • Substance use disorder (e.g. drugs or alcohol)
  • Travel or extended stay in a high-TB-incidence country
  • Exposure to a contact with active TB disease
  • Employment or residence in a congregate setting

Certain unexplained symptoms, such as a cough lasting more than 2–3 weeks, fever, night sweats, weight loss or hemoptysis (coughing up blood), also warrant evaluation for TB disease

Detect TB infection with QuantiFERON
Help protect at-risk patients with QuantiFERON-TB Gold Plus – one tube, one visit, one objective result.

How is TB spread? 

Tuberculosis spreads through the air when a person with active TB in their lungs coughs, speaks, sings or sneezes. People nearby can inhale the bacteria and become infected. TB is not spread by touching surfaces, sharing food or casual contact.

Tuberculosis in the United States

Up to 13 million people in the US are believed to carry TB infection (3). US TB cases rose for the fourth straight year in 2024, reaching their highest since 2011 (4). 

The reservoir of resurgent TB is silent TB infection. An effective program to end TB requires accurate detection of TB infection and early preventive treatment. Treating TB infection protects against debilitating TB disease – and helps stop the spread of TB. 

tuberculosis in the United States
Become a one-step are provider for

Offer single-visit TB testing for your community

Primary care providers, community health centers and urgent cares all provide front-line testing and employment screening for their communities. 

Offering single-visit TB blood testing in collaboration with your laboratory partners lets you streamline testing and helps protect your at-risk patients.

QuantiFERON-TB Gold Plus tubes

QuantiFERON is the world’s leading TB blood test

QuantiFERON-TB Gold Plus is more accurate than the skin test, unaffected by prior BCG vaccination, and uses a controlled laboratory assay to provide clear and objective results. 

References:
  1.  US CDC. Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis Infection — United States, 2010. MMWR59 RR-5
  2. World Health Organization. (2020) WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment. https://apps.who.int/iris/bitstream/handle/10665/331170/9789240001503-eng.pdf
  3. US CDC. About tuberculosis. https://www.cdc.gov/tb/about/index.html
    US CDC. Provisional 2024 tuberculosis data, United States. https://www.cdc.gov/tb-data/2024-provisional/index.html
  4. US Preventive Services Task Force. Screening for latent tuberculosis infection in adults. JAMA. 2016;316:962–969
  5. Lewinsohn DM, et al. Official ATS/IDSA/CDC clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017;64:111–115.

QFT -Plus is an in vitro diagnostic aid for detection of Mycobacterium tuberculosis infection. QFT-Plus is an indirect test for M. tuberculosis infection (including disease) and is intended for use in conjunction with risk assaessment, radiography, and other medical and diagnostic evaluations.